Limb spasticity
Drug research and approvals for limb spasticity: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 45 studies of limb spasticity are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and FDA has 2 approved and 0 open orphan designations naming it.
- Recruiting worldwide: 45
- Trials authorized in Canada: 5
- FDA orphan approvals: 2
- EU medicines: 0
- Effects of Instrument-Assisted Soft Tissue Mobilization (IASTM) Along With Conventional Physical Therapy on Upper Limb…NCT07937098 · Not applicable · Ibadat International University, Islamabad · starts Jul 9, 2026
- Effects of Functional Electrical Stimulation Combined With Task-Oriented Training on Lower Limb Function, Balance, and…NCT07924813 · Not applicable · Lahore University of Biological and Applied Sciences · starts Oct 12, 2026
- Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral PalsyNCT07902466 · Not applicable · LIFE - Research and Care Institute - Santa Lucia IRCCS · starts Oct 15, 2026
- Effectiveness of Modified Constraint-Induced Movement Therapy Versus Mirror Therapy in Spastic Hemiplegic Cerebral…NCT07747974 · Not applicable · Ibadat International University, Islamabad · starts Mar 3, 2026
- Spinal Cord Stimulation for Poststroke SpasticityNCT07744659 · Not applicable · Beijing Pins Medical Co., Ltd · starts Sep 9, 2026
- A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants…NCT07704840 · Phase 2 · Alberto Esquenazi · starts Sep 2, 2026
- Effects of Proprioceptive Neuromuscular Facilitation and Task-Oriented Training on Upper Extremity Function in Children…NCT07694804 · Not applicable · Ibadat International University, Islamabad · starts Feb 17, 2026
- Effect of Lower Extremity Modified Constraint-induced Movement Therapy on Locomotion in Children With HemiplegiaNCT07686809 · Not applicable · Cairo University · starts Jun 1, 2026
- ESTIM-UL: FES for Upper Limb Recovery After StrokeNCT07513714 · Not applicable · University of Foggia · starts May 1, 2026
| Sep 2, 2021 | A multicentre, interventional, post-marketing, randomised, double-blind, crossover study to evaluate the clinical safety and efficacy of abobotulinumtoxina…Dysport therapeutic / Botox | Ipsen | Closed |
| Jul 9, 2014 | Long-term study of botox treatment in adult patients with upper limb spasticityBotox (onabotulinumtoxina) | AbbVie | Pending |
| May 23, 2014 | Propective, randomised, double-blind, placebo-controlled, parallel-group study of the efficacy and safety of nt 201 in the unilateral treatment of essential…Nt 201 (XEOMIN) | Merz Group | Ongoing |
| May 1, 2014 | Botox treatment in adult patients with upper limb spasticityBotox | AbbVie | Closed |
| Dec 4, 2013 | Prospective, multicenter, randomized, double-blind, parallel-group, dose-response study of three doses xeomin (incobotulinumtoxin a, nt 201) for the treatment…NT201 [xeomin (incobotulinumtoxin a)] | Merz Group | Pending |
| Jun 20, 2019 | BotoxBOTOX is indicated for the treatment of upper limb spasticity in pediatric patients 2 to 17 years of age. | Allergan, Inc. | Approved |
| Jul 29, 2016 | DysportTreatment of lower limb spasticity in pediatric patients 2 years of age and older | Ipsen Biopharmaceuticals, Inc. | Approved |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA